STOCK TITAN
  1. Home
  2. Sec-filings
  3. PVLA
  4. [EFFECT] PALVELLA THERAPEUTICS, INC. SEC Filing

[EFFECT] PALVELLA THERAPEUTICS, INC. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 29, 2026 4:01 P.M.
Form: S-3
CIK: 0001583648
Company Name: PALVELLA THERAPEUTICS, INC.
File Number: 333-292544

Source: View Original Filing on SEC EDGAR

Stock PVLA logo
Palvella Therapeutics Inc

NASDAQ:PVLA

PVLA Rankings

#2916 Ranked by Market Cap
N/A Ranked by Dividends

PVLA Latest News

Feb 2, 2026
Palvella Therapeutics Announces Scientific Publication in Clinical and Experimental Dermatology Highlighting a Systematic Review of Real-World Statin Evidence and Persistent Treatment Gaps Resulting from the Lack of FDA-Approved Therapies in Porokeratosis
Jan 9, 2026
Palvella Therapeutics Provides Corporate Update and 2026 Outlook: Advancing a Late Clinical-Stage Pipeline and Platform to Address Multiple Serious, Rare Skin Diseases and Vascular Malformations with No FDA-Approved Therapies
Jan 7, 2026
Palvella Therapeutics Strengthens Leadership Team with Appointment of Veteran Medical Affairs Leader Vimal Patel, PharmD, as Senior Vice President of Medical Affairs
Dec 16, 2025
Palvella Therapeutics Granted FDA Fast Track Designation for QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Angiokeratomas
Dec 15, 2025
Palvella Therapeutics Announces Positive Topline Results from Phase 2 TOIVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Cutaneous Venous Malformations, a Serious, Rare Genetic Disease with No FDA-approved Therapies

PVLA Latest SEC Filings

Jan 29, 2026
[8-K] PALVELLA THERAPEUTICS, INC. Reports Material Event
Jan 23, 2026
[Form 4] PALVELLA THERAPEUTICS, INC. Insider Trading Activity
Jan 21, 2026
[144] PALVELLA THERAPEUTICS, INC. SEC Filing
Jan 12, 2026
[8-K] PALVELLA THERAPEUTICS, INC. Reports Material Event
Dec 15, 2025
[8-K] PALVELLA THERAPEUTICS, INC. Reports Material Event

PVLA Stock Data

907.74M
8.19M
22.86%
54.89%
6.62%
Biotechnology
Pharmaceutical Preparations
Link
United States
WAYNE